PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 219 results · Off-label Promotion  · Clear
🔒 Subscribers only
AUTH/2888/11/16
Off-label Promotion Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Napp
A hospital specialist nurse complained about a promotional email from Napp Pharmaceuticals Limited about switching from Remicade (originator infliximab) to Remsima (biosimilar infliximab).Email sub…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2885/11/16
Off-label Promotion Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Gedeon Richter
An anonymous (non-contactable) complainant, describing themselves as a senior obstetrics & gynaecology doctor, complained about an Esmya (ulipristal acetate) patient support leaflet (ref UK/ESM…
Clauses: 9.1,9.2
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2923/12/16
Off-label Promotion Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Merck Sharp & Dohme
A hospital pharmacist complained about a two-page Remicade (infliximab) advertisement by Merck Sharp & Dohme, published in The Pharmaceutical Journal (Oct–Dec 2016).Page 1 featured an intact …
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2825/3/16
Off-label Promotion Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Janssen v Boehringer Ingelheim & Lilly
Janssen-Cilag complained about a two-sided A4 “Dear UK Healthcare Professional” letter (ref UK/EMP/00241) about Jardiance (empagliflozin) cardiovascular outcomes.The letter was stapled to a rep…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2835/4/16
Off-label Promotion Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Janssen voluntary admission over outdated Invokana prescribing information email (No breach)
Janssen-Cilag’s mailing agency inadvertently sent general practitioners a previously withdrawn promotional email for Invokana (canagliflozin) (ref PHGB/VOK/1015/0078) containing outdated prescrib…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2857/7/16
Off-label Promotion Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi-Sankyo
An anonymous, non-contactable complainant raised four issues about Daiichi-Sankyo UK’s promotional activities and call rates.Allegation 1: market access consultants sent emails to customers (incl…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2848/5/16
Off-label Promotion Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Ferring
Ferring voluntarily admitted that an area sales manager encouraged representatives to facilitate a local hospital sending a letter to GP practices promoting DesmoMelt (sublingual desmopressin) inst…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2843/4/16
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Boehringer Ingelheim breached Code over
An anonymous, non-contactable complainant challenged promotion of COPD inhalers, highlighting concerns about off-label-style messaging around exacerbation reduction.The complaint focused on a Spiri…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2841/4/16
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK case AUTH/2841/4/16
An anonymous complainant alleged off-label promotion of LABA/LAMA inhalers for COPD exacerbation reduction, focusing on GSK’s Anoro Ellipta (vilanterol/umeclidinium). The complainant highlighted …
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2840/4/16
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Novartis & Pfizer
An anonymous, non-contactable complainant alleged that COPD inhalers licensed to relieve symptoms were being promoted as if indicated to reduce exacerbations.Products: Ultibro Breezhaler (indacater…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2914/12/16
Off-label Promotion Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Pierre Fabre
A hospital pharmacist complained (on behalf of a group) about clear plastic bags for Navelbine (vinorelbine) Oral capsules supplied via Pierre Fabre representatives to hospital pharmacies.The bags …
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2875/9/16
Off-label Promotion Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Recordati breached the Code over misleading guideline and “lowest volume” claims in Cleen/CitraFleet
A health professional complained about a two-page print advertisement for Cleen and CitraFleet published in Gastrointestinal Nursing (September 2016).The ad headline referred to “two remarkable e…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2802/11/15
Off-label Promotion Upheld 🏥 Oncology ▶ Video 🎙 Podcast
ALK-Abelló v Bausch & Lomb
ALK-Abelló UK complained about a promotional article published in Pulse as a “Pulse Quick Guide” titled “New approaches in management and treatment of anaphylaxis”.The guide discussed adre…
Clauses: 4.1,4.8,9.1
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2810/12/15
Off-label Promotion Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Teva breached ABPI Code over ‘intuitive’ inhaler ad for DuoResp Spiromax (AUTH/2810/12/15)
An anonymous, non-contactable complainant (self-described GP) challenged a Teva UK advertisement for DuoResp Spiromax placed in Primary Care Respiratory Update.The ad featured a patient image with …
Clauses: 3.1,3.2
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2801/11/15
Off-label Promotion Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Janssen
Janssen-Cilag voluntarily admitted that a two-page bound insert advertisement for Stelara (ustekinumab) in the Annals of Rheumatic Disease (ARD) October 2015 issue contained outdated prescribing in…
Clauses: 4.9,9.1
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2796/9/15
Off-label Promotion Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Bausch & Lomb breached ABPI Code over Pulse “Quick Guide” on anaphylaxis
A GP complained about a laminated A4 “Pulse Quick Guide” titled “New approaches in management and treatment of anaphylaxis”, supplied with Pulse.The guide discussed adrenaline auto-injector…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2794/9/15
Off-label Promotion Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Bayer v Actavis
Bayer complained about a four-page Levosert leavepiece (ref UK/LE/0001/01-15b) issued by Actavis UK Ltd.The leavepiece headline asked: “Can a single IUS be suitable for so many women?”The leave…
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2778/7/15
Off-label Promotion Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Ipsen
Merz complained about two Ipsen leavepieces promoting Dysport (botulinum toxin type A) that discussed dose ratios versus other BoNT-A products (including Xeomin and Botox).Leavepiece 1 (ref UK/DYS0…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2776/7/15
Off-label Promotion Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Bayer
Bristol-Myers Squibb and Pfizer complained about a Xarelto (rivaroxaban) gate-fold leavepiece: “For elderly patients taking aspirin for stroke prevention… It’s time to rethink their protectio…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2774/6/15
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Pfizer gabapentin pharmacy “patient alert” on PMR systems
A head of medicines management (CCG) complained about a Pfizer-supported “patient alert” that appeared on some community pharmacy electronic dispensing/PMR systems when gabapentin was entered/d…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2758/5/15
Off-label Promotion Upheld 🏥 Other ▶ Video 🎙 Podcast
Stirling Anglian
Galen complained about Stirling Anglian’s promotion of CosmoCol (Macrogol 3350 plus electrolytes) via (1) an “abbreviated advertisement” in MIMS (March 2015) and (2) a one-page leavepiece (pr…
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2755/5/15
Off-label Promotion Not Upheld 🏥 Musculoskeletal & Bone ▶ Video 🎙 Podcast
A Menarini misleading cost messaging and email permission failures in
A head of medicines optimisation complained about a promotional email sent by A Menarini to payers, formulary committees, prescribing advisors and medicines management teams.The email/attachment hi…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2751/3/15
Off-label Promotion Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
ViiV Healthcare
An anonymous general practitioner complained about a ViiV Healthcare UK Triumeq advertisement published in the hospital edition of the BMJ (14 March 2015; UK/TRIM/0022/14A).The ad headline stated: …
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2750/3/15
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
Actelion complained about two GlaxoSmithKline UK leavepieces for Volibris (ambrisentan) used with clinicians in UK adult PAH reference centres.Leavepiece A (ref UK/ABT/0023/14) was a 4-page chart t…
Clauses: NONE
2015 🔒 Subscribe
← Prev 1 2 3 4 5 6 7 Next → Page 4 of 10 — 219 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews